The Primary Care Journal Club

The Primary Care Journal ClubThe Primary Care Journal ClubThe Primary Care Journal ClubThe Primary Care Journal Club
  • Home
  • Critical Appraisal Blogs
  • About us
  • Rational testing
  • Glossary
  • Patient questions
  • Clinical topics
  • BNF Treatment Summaries

The Primary Care Journal Club

The Primary Care Journal ClubThe Primary Care Journal ClubThe Primary Care Journal Club
  • Home
  • Critical Appraisal Blogs
  • About us
  • Rational testing
  • Glossary
  • Patient questions
  • Clinical topics
  • BNF Treatment Summaries

Glossary

Glossary of terms in alphabetical order

 

Absolute risk vs relative risk 


Absolute Risk: Refers to the actual probability of an event occurring in a specific population. It is the number of people experiencing an event in relation to the total population at risk. 


Relative Risk: Compares the risk of an event occurring between two different groups. It is expressed as a ratio, showing how much more (or less) likely an event is to occur in one group compared to another. 


Example: If a medication reduces the risk of developing a disease from 10% to 5%, the absolute risk reduction is 5%, while the relative risk reduction is 50%. This is why journalists and drug companies love relative risk, it always makes things seem more impressive.


Likelihood ratios


Likelihood ratios (LRs) help you understand how much a test result changes the chance of a disease. In simple terms, a positive likelihood ratio (LR+) tells you how much more likely it is for a patient with a positive test to have the disease compared to someone without it. Conversely, a negative likelihood ratio (LR–) shows how much less likely a patient with a negative test is to have the disease. If the LR+ is high (for example, above 10) or the LR– is very low (below 0.1), the test result significantly alters your initial estimate (pre-test probability) of disease. When LRs are close to 1, the test adds little value because it barely changes your estimate. This way of thinking makes it easier to decide whether a test result is truly meaningful in guiding treatment decisions. 


Meta-analysis


You take several separate studies on the same topic and combine their results into one big study. By pooling all this data, you get a clearer overall picture of what’s really happening. This combined approach, called a meta-analysis, often provides stronger, more reliable evidence than you’d get from looking at each study on its own. 


Number Needed to Treat (NNT)

  • First you find the absolute risk reduction (ARR), which is the difference in the event rate between the control group (often given a placebo) and the treatment group.
  • You then calculate the NNT by taking the inverse of the ARR. Mathematically, this is: NNT= 1/ARR
  • Worked example for (NNT):
    • In the control group, 10% of patients experience a heart attack.
    • In the treatment group, only 5% of patients experience a heart attack.
    • The ARR is 10% – 5% = 5%, or 0.05 in decimal form.
    • The NNT is then: NNT=1/0.05 = 20 
    • Interpretation: You need to treat 20 patients with this drug to prevent one heart attack.


Number Needed to Harm (NNH)

  • Similarly, if a treatment increases the risk of a negative event (an adverse effect), you calculate the absolute risk increase (ARI).
  • The NNH is the inverse of the ARI: NNH= 1/ARI


Randomised Controlled Trial 


You randomly split participants into different groups – one receives the new treatment, and another might receive a “dummy” pill (also known as a placebo) or standard care. Because you assign them randomly, any differences in outcomes are more likely to come from the treatment itself rather than other factors. This method is called a Randomised Controlled Trial (RCT). 

The Primary Care Journal Club

Copyright © 2025 The Primary Care Journal Club - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept